Eversept Partners »

Evommune shares owned by Eversept Partners

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 55k 22.99

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
GSK Sponsored Adr (GSK)
Vera Therapeutics Cl A (VERA)
Natera (NTRA)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Qiagen Nv Ord Shares (QGEN)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Hca Holdings (HCA)

View all positions for Eversept Partners

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
Rtw Investments
MPM Oncology Impact Management
Nan Fung Group Holdings
SymBiosis Capital Partners
Eventide Asset Management
Henderson Group
Marshall Wace
Baker Bros. Advisors
Alyeska Investment Group
Defilade Capital Management
BlackRock

View all funds holding Evommune